Expanded use of CBD in medical research gets FDA approval

Expanded use of CBD in medical research gets FDA approval

The FDA is allowing expanded use of hemp-derived CBD products in medical research under certain conditions, while maintaining federal oversight and safety standards.

Feds Finalize New Rule Allowing Some Hemp Products As Medicare Advantage Benefits

Federal officials have finalized a rule that will allow coverage of some hemp products as specialized, non-primarily health-related benefits through Medicare Advantage (MA) plans. In a filing set to be published in the Federal Register on Monday, the Centers for Medicare & Medicaid Services (CMS) is clarifying that certain cannabis products that are legal under both state and federal laws are eligible to be reimbursed under the Special Supplemen…

Edible Brands Executive Says FDA’s CBD Policy Could Support a Supplement-Style Edibles Framework, but Broader Reform Is Still Needed

The Marijuana Herald - Marijuana news and information A newly announced FDA policy on certain hemp-derived CBD products is drawing support from Edible Brands, which says the agency’s enforcement approach could help validate a supplement-style arrangement for edibles in healthcare settings. Edible Brands is the parent company of Edible Arrangements and Edibles.com. While the policy remains narrowly limited to specific Medicare-related circumstanc…